Skip to main content

Table 2 Shortlisted invariant RvIDs

From: Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis

S.no

RvIDs/gene names

Functions

Docking with corresponding NS with targets (PDB ID)

Computationally proposed GSK Compound (Docking score)

Other leads generated from 426 GSK molecules (Docking Score)

1

Rv2763c, dfrAa,b, d

Essential step for de novo glycine and purine

Yes (1DG5)

Total 24 inhibitors

CHEMBL2098242 (Docking score = − 10.28)

SB-439950 (Docking score = − 10.88) and CHEMBL2098242 (Docking score = − 10.28)

2

Rv1094, desA2a

Conversion of saturated fatty acids to unsaturated fatty acids

No NS (1ZA0)

GR119270B (Docking score = − 5.09)

CHEMBL535116 (Docking score = − 6.79)

3

Rv3247c, tmka

Probable Thymidylate Kinase TMK

(dTMP Kinase) (Thymidilic Acid Kinase)

Yes (1G3U)

GW663013X (Docking score = − 2.60)

CHEMBL2098151 (Docking score = − 11.08)

4

Rv3607c, folBa, c, d

Dihydroneopterinaldolase

Yes (1NBU)

GSK2168465A (Docking score = − 4.2)

CHEMBL2097950 (Docking score = − 6.88)

5

Rv3048c, nrdF2a

Involved in the DNA replication pathway

No NS (1UZR)

GR119270B (Docking score = − 3.90)

CHEMBL2098385 (Docking score = − 9.01)

6

Rv2965c, kdtB

Phosphopantetheineadenylyltransferase

No NS (3PNB)

SKF-67461 (Docking score = − 3.39)

CHEMBL2097847 (Docking score = − 6.92)

7

Rv2361c, uppSa, c (No GSK inhibitor reported)

Z-decaprenyl

Diphosphatesynthase

Yes (2VG2)

No reported inhibitor

CHEMBL2098151 (Docking score = − 12.62)

  1. aEssentiality based on experimental results
  2. bEssentiality based on in silico analysis
  3. cMetabolic Persister Genes
  4. dMD Simulations performed